Oncology Today with Dr Neil Love cover image

Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review

Oncology Today with Dr Neil Love

00:00

Would He Use Yonalimab Now?

Hanny affirms he'd use yonalimab in VEHIT-2‑like and refractory patients, seeking durable off-treatment responses and disease modification.

Play episode from 04:30
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
 Get the app